Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2023-10-01
2024-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
CGF-Enhanced Autologous Pulp Transplantation in Mature Necrotic Teeth
NCT07314866
Comparison Between Two Regenerative Scaffolds
NCT06227533
CGF and PRF in the Gingival Recessions Treatment
NCT04261634
Evaluation of Different Scaffolds in Regenerative Endodontic Treatment
NCT06945965
Efficacy of Combined Blood Clot and Platelet Rich Fibrin Scaffolds in Regeneration of Necrotic Immature Permanent Teeth
NCT04390854
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Radiographic evaluation involved cone-beam computed tomography (CBCT) at baseline and 12 months to measure root length development, apical diameter changes, hard tissue formation, and volumetric alterations in periapical lesions. Periapical radiographs were taken at baseline, 6 months, and 12 months to complement CBCT findings. Clinical follow-up included assessment of symptoms such as pain, swelling, sinus tract presence, tenderness to percussion, and pulp sensitivity using cold testing and electric pulp testing.
The primary aim of this study was to compare the effects of scaffold type and EDTA concentration on the biological and radiographic outcomes of regenerative endodontic treatment. The study sought to clarify how these variables may influence root maturation, apical closure, pulp vitality responses, and periapical tissue healing within a regenerative framework. This research was designed to contribute to the optimization of clinical protocols for managing immature teeth with necrotic pulps.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Blood Clot + 5% EDTA
Standard regenerative endodontic treatment using final irrigation with 5% EDTA followed by induction of bleeding to form a blood clot scaffold.
Blood Clot + 5% EDTA
Final irrigation with 5% EDTA followed by induction of apical bleeding to form an intracanal blood clot scaffold as part of the regenerative endodontic procedure.
Blood Clot + 17% EDTA
Regenerative endodontic procedure using final irrigation with 17% EDTA and blood clot scaffold formation.
Blood Clot + 17% EDTA
Final irrigation with 17% EDTA followed by controlled induction of bleeding beyond the apex to produce a blood clot scaffold for regenerative endodontic treatment.
PRF + 5% EDTA
Regenerative endodontic procedure using platelet-rich fibrin scaffold after final irrigation with 5% EDTA.
PRF + 5% EDTA
Application of platelet-rich fibrin (PRF) scaffold after final irrigation with 5% EDTA during regenerative endodontic therapy.
PRF + 17% EDTA
Regenerative endodontic procedure using platelet-rich fibrin scaffold following final irrigation with 17% EDTA.
PRF + 17% EDTA
Use of platelet-rich fibrin (PRF) scaffold following final irrigation with 17% EDTA in regenerative endodontic treatment.
CGF + 5% EDTA
Regenerative endodontic protocol using concentrated growth factor scaffold after final irrigation with 5% EDTA.
CGF + 5% EDTA
Placement of concentrated growth factor (CGF) scaffold after final irrigation with 5% EDTA as part of the regenerative endodontic protocol.
CGF + 17% EDTA
Regenerative endodontic procedure using concentrated growth factor scaffold following final irrigation with 17% EDTA.
CGF + 17% EDTA
Placement of concentrated growth factor (CGF) scaffold following final irrigation with 17% EDTA during regenerative endodontic treatment.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood Clot + 5% EDTA
Final irrigation with 5% EDTA followed by induction of apical bleeding to form an intracanal blood clot scaffold as part of the regenerative endodontic procedure.
Blood Clot + 17% EDTA
Final irrigation with 17% EDTA followed by controlled induction of bleeding beyond the apex to produce a blood clot scaffold for regenerative endodontic treatment.
PRF + 5% EDTA
Application of platelet-rich fibrin (PRF) scaffold after final irrigation with 5% EDTA during regenerative endodontic therapy.
PRF + 17% EDTA
Use of platelet-rich fibrin (PRF) scaffold following final irrigation with 17% EDTA in regenerative endodontic treatment.
CGF + 5% EDTA
Placement of concentrated growth factor (CGF) scaffold after final irrigation with 5% EDTA as part of the regenerative endodontic protocol.
CGF + 17% EDTA
Placement of concentrated growth factor (CGF) scaffold following final irrigation with 17% EDTA during regenerative endodontic treatment.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of pulp necrosis
* Radiographic evidence of periapical pathology
* Teeth suitable for isolation and restoration
* Patients aged 9 to 25 years
* No systemic diseases that contraindicate dental treatment
* Willingness to attend follow-up visits
* Signed informed consent by patient or guardian
Exclusion Criteria
* Teeth with severe canal curvature (\>30°)
* Teeth with advanced root resorption
* Periodontal pocket depth \>3 mm
* Previous endodontic treatment or retreatment
* Pregnancy
* Use of antibiotics or analgesics within the last 7 days
* Nonrestorable crowns
* Uncooperative patients unable to attend follow-up
9 Years
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kahramanmaras Sutcu Imam University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aliye Kamalak
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aliye Kamalak
Role: PRINCIPAL_INVESTIGATOR
Kahramanmaraş Sütçü İmam University, Faculty of Dentistry, Department of Endodontics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kahramanmaraş Sütçü İmam University, Faculty of Dentistry
Kahramanmaraş, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2024/3-14 D
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
RET-EDTA-Study-2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.